Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |